About
Medhealth Clinical is a biotechnology and research company focused on developing effective drug delivery systems and medical treatments for chronic illness. Our work centres on NanoCelle, a patented sub-micron delivery platform.
Overview
Mission. To advance drug delivery so medicines can be administered more practically, more consistently and less invasively.
Vision. A therapeutic landscape in which delivery is designed deliberately, not inherited by default.
Scientific approach. Hypothesis-led formulation research, molecule-specific characterisation, and communication proportionate to evidence.
Presence. Research and company activity across Australia and the United States.
Our people
Scientific culture
History
History
Leadership
Dr Sean Hall founded Medhealth Clinical in 2012 and has more than two decades of experience spanning healthcare, early-stage drug discovery and life sciences. His work has focused on translating scientific research into practical development opportunities, with particular emphasis on drug-delivery technologies and patient-focused innovation.
Founder, Medhealth Clinical
Professor Luis Vitetta is a medical researcher and academic whose work spans clinical research, integrative medicine, nutritional science and the investigation of therapeutic approaches to human health. As Chief Medical Officer, he contributes medical and scientific expertise to Medhealth’s research and development activities.
Chief Medical Officer, Medhealth Clinical
Dr Jacob Wolfe is a scientist with extensive experience in pharmaceutical development, formulation science and drug-delivery technology. His work has included organic chemistry and nano-micellar technology, bringing technical expertise to the development and application of advanced delivery systems.
Chief Science Officer, Medhealth Clinical
Industry engagement
Medhealth Clinical works with research institutions, clinical investigators and industry partners where scientific objectives and development pathways align.
Entity, governance and registered office details will be added as they are confirmed.
Contact
Whether you are a scientist, clinician, potential partner or investor, the team is available to discuss the platform and its research direction.
